Medication Review in Women With Depression and Anxiety

Depression, Anxiety Clinical Trial

Official title:

Assessing the Impact of Medication Management Review Service for Females Diagnosed With Depression and Anxiety

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04082871
• Other study ID #: 1IRB/2016/04
• Status: Completed
• Phase: N/A
• Start date: August 1, 2016
• Est. completion date: January 10, 2017

Study information

• Verified date: September 2019
• Source: Applied Science Private University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Description:

Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 73
• Est. completion date: January 10, 2017
• Est. primary completion date: January 1, 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period),

• above the age of 18 years

• diagnosed with depression and/or anxiety for at least 4 weeks duration

• taking medications for depression and/or anxiety

Exclusion Criteria:

• presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist)

• being not able to speak or write Arabic (reported by the patient)

Related Conditions & MeSH terms

• Adherence, Patient
• Anxiety Disorders
• Depression
• Depression, Anxiety
• Depressive Disorder

Intervention

Other:
• Medication management review
The researcher screened each completed an MMR template and verified that all information in each patient template was complete. A classification system was then used to identify the TRPs which either actually or potentially interfered with the clinical outcomes for each patient.[19] This system was explained in detail and applied successfully in many previous studies.[10, 14, 20] The researcher then identified TRPs for each patient in both groups using evidence-based medicine. The TRPs including unneeded drug treatment, untreated condition/s, efficacy/effectiveness issues, safety issues, inadequate knowledge, inappropriate adherence to pharmacological therapy, inappropriate adherence to self-care activities and miscellaneous problems.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Applied Science Private University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate the effect of the medication management review service delivered to females living in Jordan and diagnosed with depression and anxiety	the medication management review service will be measured by the reduction of treatment related number after providing the service	6 months
Secondary	Patient's satisfaction with the medication management review service	satisfaction will be measured by the willingness of patients to pay for the provided services	6 months